Oncternal Therapeutics Inc (ONCT)
Market Open
2 Dec, 21:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 53
-0.17
-24.121%
$
1.56M Market Cap
- P/E Ratio
- Div Yield
644,135 Volume
-10.66 Eps
$ 0.69
Previous Close Want to track ONCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oncternal Therapeutics Inc (ONCT) Statistics
Valuation metrics
Market Cap 1.56M
Enterprise value -4.82M
Trailing P/E (ttm) -0.04
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 1.99
Price/Book (mrq) 0.05
Enterprise Value/Revenue -6.14
Enterprise Value/EBITDA -2.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.53
52-Week high 10.61
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 8 Jan 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -50.29%
Operating margin -53.14%
Operational effectiveness
Return on assets -1.07%
Return on equity 0.62%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.27
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -13.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.65
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 6.94%
Book value per share (mrq) 10.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
